NEW YORK (360Dx) – DiaSorin this week completed its acquisition of Siemens Healthineer's microtiter-based ELISA immunodiagnostic business portfolio and related assets. The deal was originally announced in July. The deal does not include the transfer of employees or the manufacturing facility and capability, DiaSorin said. Siemens will continue to manufacture and exclusively provide its ELISA immunodiagnostic reagent kits to DiaSorin for up to three years.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.